Mercor is seeking a disease-area clinician to participate in a paid pilot evaluating and critiquing rubrics that analyze commercial drugs and drug-development programs. You will interpret trial endpoints and judge whether results would change prescribing, applying insights across the pilot's drugs and programs.
The engagement is remote for US-based clinicians, expected to be 10–20 hours over 1–2 weeks, with potential recurring engagement for strong contributors.
#J-18808-LjbffrRemote Disease-Area Clinician & Drug-Development Evaluator in new york at Unknown Company
This position is listed as full time and able to be worked remotely.